ArticleAIDS and behavior2026
Not Getting to Zero HIV Among Men Who Have Sex with Men in San Francisco Despite High Care Continuum and Prevention Targets.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
New HIV diagnoses among men who have sex with men (MSM) in San Francisco decreased by 77% from 2012 to 2021, presenting an encouraging trajectory toward zero infections by 2030. Unfortunately, the trajectory has slowed in recent years, with an uptick in new diagnoses from 2021 to 2022. We assessed the current HIV epidemic status and progress towards achieving the 95-95-95 HIV care continuum and prevention targets among MSM in San Francisco. Time-location sampling was used to sample MSM, recruiting at physical and online venues at randomly chosen venue-day-time periods from June to November 2023. HIV status was obtained by rapid testing; HIV care and prevention engagement were self-reported. Among 545 MSM, HIV prevalence was 24.4%. Prevalence was highest (48.8%) among Black/African American MSM. Of 132 living with HIV, 97.7% were aware of their status, of whom 97.7% were on antiretroviral therapy (ART), of whom 90.5% reported being virally suppressed. Among MSM not living with HIV, 80.0% had an HIV test, 56.5% used pre-exposure prophylaxis (PrEP), 27.9% consistently used condoms, and 9.2% used post-exposure prophylaxis (PEP) in the past 12 months. MSM in San Francisco in 2023 exceeded the first (status awareness) and second (ART use) pillars of the shared global 95-95-95 targets, and was greater than 90% for the third (viral suppression). Our current prevention tools are reaching diminishing returns. New medical interventions may also have a marginal impact unless we first address social and structural barriers that continue to result in HIV disparities and PrEP inequities.
Indexed as
Identifiers
41075057What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.